Bruker Takes Equity Stake, Sells 51 Mass Spec Machines to GeneProt | GenomeWeb

NEW YORK,   Sept 12 - Bruker Daltonics (Nasdaq: BDAL) of Billerica, Mass., said Tuesday it would sell 51 mass spectrometry machines to Geneva Proteomics as well as take an equity stake in the Swiss company.

Financial terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.